Drug Shortage Report for GALANTAMINE ER

Last updated on 2024-01-30 History
Report ID 200443
Drug Identification Number 02443015
Brand name GALANTAMINE ER
Common or Proper name GALANTAMINE ER
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) GALANTAMINE
Strength(s) 8MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-07-31
Estimated end date 2024-01-22
Actual end date 2024-01-18
Shortage status Resolved
Updated date 2024-01-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2024-01-30 French Compare
v16 2024-01-30 English Compare
v15 2024-01-17 French Compare
v14 2024-01-17 English Compare
v13 2023-12-26 French Compare
v12 2023-12-26 English Compare
v11 2023-11-22 French Compare
v10 2023-11-22 English Compare
v9 2023-10-23 French Compare
v8 2023-10-23 English Compare
v7 2023-08-29 French Compare
v6 2023-08-29 English Compare
v5 2023-08-22 French Compare
v4 2023-08-22 English Compare
v3 2023-08-01 English Compare
v2 2023-07-31 French Compare
v1 2023-07-31 English Compare

Showing 1 to 17 of 17